Key facts
- This page summarizes Karen L. Smith's Form 4 filing for Aurinia Pharmaceuticals Inc. (AUPH).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Nov 2024, 19:20.
Karen L. Smith - 08 Nov 2024 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)
- Reporting relationship
- Director
- Issuer ticker
- AUPH
- Reported as of
- 08 Nov 2024
- Net transaction value
- -$44,182
- SEC form
- 4
- Accepted by SEC
- 12 Nov 2024, 19:20:36 UTC
- Prior SEC filing
- 30 Oct 2024
- Next SEC filing
- 25 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Karen L. Smith
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Karen L. Smith filed Form 4 for Aurinia Pharmaceuticals Inc. (AUPH) on 12 Nov 2024.
Change
- Previous filing in this sequence was filed on 30 Oct 2024.
- Current net transaction value: -$44,182.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AUPH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +17,913
- Change %
- Price
- Shares after
- 17,913
- Date
- 08 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
AUPH
transaction
Common Stock
Sale
- Transaction value
- $44,182
- Shares
- -5,241
- Change %
- -29%
- Price
- $8.43
- Shares after
- 12,672
- Date
- 11 Nov 2024
- Ownership
- Direct
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AUPH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -17,913
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,913
- Exercise price
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.
Footnote F3
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.37 to $8.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Footnote F4
The RSUs vested one year from date of grant and have no expiration date.